From: Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-κB signaling
ASS
Positive
Negative
Survivin
11 (41%)
14 (41%)
8 (15%)
1 (3%)*